Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Product

AZR-MD-001

Aliases
AZR-MD-001 ointment/semi-solid drug, AZR-MD-001 Vehicle

5 clinical trials

4 indications

Indication
Meibomian Gland Dysfunction
Indication
Dry Eye
Indication
Contact Lens Discomfort
Indication
Dry Eye Syndrome
Clinical trial
A Multicenter, Vehicle-controlled, Randomized Study to Evaluate the Safety, Tolerability, Systemic Pharmacokinetics, and Pharmacodynamics of AZR-MD-001 in Patients With Meibomian Gland Dysfunction (MGD) and Evaporative Dry Eye Disease (DED)
Status: Completed, Estimated PCD: 2022-09-14
Clinical trial
A Two Stage, Multi-center, Vehicle-controlled, Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of AZR-MD-001 and to Determine Common Symptoms in Contact Lens Discomfort (CLD)
Status: Completed, Estimated PCD: 2023-10-13
Clinical trial
A Single-center, Vehicle-controlled, Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of AZR-MD-001 as Adjunctive Therapy to Conventional Therapeutic Treatment for Meibomian Gland Dysfunction (MGD) or Contact Lens Discomfort (CLD)
Status: Completed, Estimated PCD: 2020-12-11
Clinical trial
A Single-center, Vehicle-controlled, Study to Evaluate Methods to Enhance AZR-MD-001 for Meibomian Gland Dysfunction (MGD)
Status: Completed, Estimated PCD: 2021-01-06
Clinical trial
A Phase 3, Multicenter, Vehicle-controlled, Randomized Study to Evaluate the Efficacy, Safety, and Tolerability of AZR-MD-001 in Patients With Abnormal Meibomian Gland Function and Associated Symptoms of Dry Eye Disease (DED)
Status: Not yet recruiting, Estimated PCD: 2024-12-01